IS6588A - Sodium-hydrogen alternate type 1 inhibitor (NHE-1) - Google Patents

Sodium-hydrogen alternate type 1 inhibitor (NHE-1)

Info

Publication number
IS6588A
IS6588A IS6588A IS6588A IS6588A IS 6588 A IS6588 A IS 6588A IS 6588 A IS6588 A IS 6588A IS 6588 A IS6588 A IS 6588A IS 6588 A IS6588 A IS 6588A
Authority
IS
Iceland
Prior art keywords
nhe
inhibitor
sodium
alternate type
hydrogen
Prior art date
Application number
IS6588A
Other languages
Icelandic (is)
Inventor
George Chen Weichao
David Cox Eric
Guzman-Perez Angel
Original Assignee
Pfizer Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products, Inc. filed Critical Pfizer Products, Inc.
Publication of IS6588A publication Critical patent/IS6588A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS6588A 2000-04-28 2002-10-21 Sodium-hydrogen alternate type 1 inhibitor (NHE-1) IS6588A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number Publication Date
IS6588A true IS6588A (en) 2002-10-21

Family

ID=22741697

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6567A IS6567A (en) 2000-04-28 2002-09-24 Sodium-hydrogen type 1 interlayer (NHE-1)
IS6588A IS6588A (en) 2000-04-28 2002-10-21 Sodium-hydrogen alternate type 1 inhibitor (NHE-1)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS6567A IS6567A (en) 2000-04-28 2002-09-24 Sodium-hydrogen type 1 interlayer (NHE-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (en)
JP (1) JP2003531900A (en)
KR (1) KR20020093079A (en)
CN (1) CN1225466C (en)
AP (1) AP2002002651A0 (en)
AR (1) AR028375A1 (en)
AU (1) AU2001235896A1 (en)
BG (1) BG107139A (en)
BR (1) BR0110268A (en)
CA (1) CA2407535A1 (en)
CO (1) CO5221125A1 (en)
CR (1) CR6797A (en)
CZ (1) CZ20023408A3 (en)
DZ (1) DZ3310A1 (en)
EA (1) EA004882B1 (en)
EE (1) EE200200615A (en)
GT (1) GT200100064A (en)
HN (1) HN2001000042A (en)
HR (1) HRP20020851A2 (en)
HU (1) HUP0300651A2 (en)
IL (1) IL152075A0 (en)
IS (2) IS6567A (en)
MA (1) MA26897A1 (en)
MX (1) MXPA02010600A (en)
MY (1) MY133842A (en)
NO (1) NO20025132L (en)
NZ (1) NZ521348A (en)
OA (1) OA12256A (en)
PA (1) PA8513301A1 (en)
PE (1) PE20011270A1 (en)
PL (1) PL357765A1 (en)
SK (1) SK14872002A3 (en)
SV (1) SV2002000418A (en)
TN (1) TNSN01065A1 (en)
TR (1) TR200202439T2 (en)
UA (1) UA73348C2 (en)
UY (1) UY26680A1 (en)
WO (1) WO2001083470A1 (en)
YU (1) YU79602A (en)
ZA (1) ZA200208605B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518686A (en) * 2001-01-31 2004-06-24 ファイザー・プロダクツ・インク Ethanolates of sodium-hydrogen exchange transporter type 1 inhibitors
EP1456181A1 (en) * 2001-12-19 2004-09-15 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
MXPA04008646A (en) * 2002-05-02 2004-12-06 Pfizer Prod Inc Treatment of diabetes and diabetic complications with nhe-1 inhibitors.
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
ES2220185B1 (en) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas NEW INHIBITOR PEPTIDE OF THE NA + / H + EXCHANGER (PINHE), AND ITS APPLICATIONS.
MXPA05008612A (en) * 2003-02-14 2005-12-05 Smithkline Beecham Corp Novel compounds.
RU2518741C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739403B2 (en) * 1998-02-27 2001-10-11 Pfizer Products Inc. N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
EE200200615A (en) 2004-04-15
WO2001083470A1 (en) 2001-11-08
UA73348C2 (en) 2005-07-15
HN2001000042A (en) 2001-07-09
HUP0300651A2 (en) 2003-07-28
HRP20020851A2 (en) 2005-02-28
JP2003531900A (en) 2003-10-28
IL152075A0 (en) 2003-05-29
UY26680A1 (en) 2001-12-28
TR200202439T2 (en) 2003-02-21
SV2002000418A (en) 2002-07-03
SK14872002A3 (en) 2004-03-02
AR028375A1 (en) 2003-05-07
CN1225466C (en) 2005-11-02
OA12256A (en) 2003-11-06
CA2407535A1 (en) 2001-11-08
MA26897A1 (en) 2004-12-20
PA8513301A1 (en) 2003-09-05
EA200201023A1 (en) 2003-02-27
CO5221125A1 (en) 2002-11-28
PE20011270A1 (en) 2001-12-12
GT200100064A (en) 2002-03-22
CR6797A (en) 2004-05-17
BG107139A (en) 2003-07-31
NO20025132D0 (en) 2002-10-25
AU2001235896A1 (en) 2001-11-12
IS6567A (en) 2002-09-24
EP1276737A1 (en) 2003-01-22
EA004882B1 (en) 2004-08-26
PL357765A1 (en) 2004-07-26
KR20020093079A (en) 2002-12-12
ZA200208605B (en) 2003-10-24
MXPA02010600A (en) 2003-03-10
YU79602A (en) 2006-05-25
DZ3310A1 (en) 2001-11-07
AP2002002651A0 (en) 2002-12-31
CZ20023408A3 (en) 2004-01-14
NO20025132L (en) 2002-12-12
NZ521348A (en) 2004-09-24
BR0110268A (en) 2003-12-30
TNSN01065A1 (en) 2005-11-10
MY133842A (en) 2007-11-30
CN1426404A (en) 2003-06-25

Similar Documents

Publication Publication Date Title
DK1064298T3 (en) Inhibitors of caspases
NO20030845L (en) Selected condensed pyrrolocarbazoles
ATE398611T1 (en) PARA-AMINE SUBSTITUTED PHENYLAMIDE GLUCOCINASE ACTIVATORS
DZ3318A1 (en) PROTEINASE INHIBITOR
DE50103020D1 (en) POSITIONING
ATE307121T1 (en) SUBSTITUTED ARYLPYRAZINE
AR028393A1 (en) SUBSTITUTED IMINOAZIDS
DE50110260D1 (en) COOLING CIRCUIT
DE60130271D1 (en) pallet holder
DE50007505D1 (en) positioning
ATE365721T1 (en) SUBSTITUTED BENZOYLCYCLOHEXENONES
AR028302A1 (en) SUBSTITUTED FENILURACILOS
IS6588A (en) Sodium-hydrogen alternate type 1 inhibitor (NHE-1)
DE60132814D1 (en) TE
DE69903779D1 (en) Inhibitor switch
DE60122192D1 (en) CIRCUIT
DE60112941D1 (en) CIRCUIT
DE60127966D1 (en) CIRCUIT
DE60117837D1 (en) CIRCUIT
DE50108778D1 (en) Dialkyne compounds
DE60113842D1 (en) CIRCUIT
FI20000264A (en) Magazine paper
NO20000210D0 (en) Spann Holder
FI20000385A (en) ISDN search (hunting)
NO20001572D0 (en) Meisel Tools